Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen

Hsu Y.-C.Mo L.-R.Chang C.-Y.MING-SHIANG WUJIA-HORNG KAOWang W.-L.Yang T.-H.Wang C.-S.Chiang M.-F.CHIEH-CHANG CHENYU-JEN FANGHung H.-W.Wu C.-Y.Lin J.-T.2021-09-042021-09-0420161542-3565https://www.scopus.com/inward/record.uri?eid=2-s2.0-84991037837&doi=10.1016%2fj.cgh.2016.03.024&partnerID=40&md5=95fbbbd269ee1aacf5beba2dcd84e14ehttps://scholars.lib.ntu.edu.tw/handle/123456789/581901[SDGs]SDG3Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patientsjournal article10.1016/j.cgh.2016.03.024270182992-s2.0-84991037837